Cost-effectiveness analysis of chlorhexidine-alcohol versus povidone iodine-alcohol solution in the prevention of intravascular-catheter-related bloodstream infections in France

PLoS ONE

Volumn 13, Issue 5, 2018, Pages

  Maunoury, Franck ^a   Farinetto, Christian ^a   Ruckly, Stéphane ^b   Guenezan, Jeremy ^c   Lucet, Jean Christophe ^d   Lepape, Alain ^e   Pascal, Julien ^f   Souweine, Bertrand ^f   Mimoz, Olivier ^c   Timsit, Jean François ^g  

^a Technopôle de l'Université   (France)

^b Department of Biostatistics   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

^d BICHAT HOSPITAL   (France)

^e CENTRE HOSPITALIER LYON SUD   (France)

^f UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; POVIDONE IODINE; 2 PROPANOL; ALCOHOL; ALCOHOL DERIVATIVE;

ADULT; ANTISEPSIS; ARTICLE; CATHETER INFECTION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; FEMALE; FRANCE; HEALTH CARE COST; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; MONTE CARLO METHOD; SEMI MARKOVIAN MODEL; BACTEREMIA; CLINICAL TRIAL; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; ECONOMIC MODEL; ECONOMICS; FUNGEMIA; MULTICENTER STUDY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

2-PROPANOL; ALCOHOLS; BACTEREMIA; CATHETER-RELATED INFECTIONS; CHLORHEXIDINE; COST-BENEFIT ANALYSIS; ETHANOL; FEMALE; FRANCE; FUNGEMIA; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MODELS, ECONOMIC; POVIDONE-IODINE; TREATMENT OUTCOME;

EID: 85047545702     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0197747     Document Type: Article

References (22)

1. Suetens C, Morales I, Savey A, Palomar M, Hiesmayr M, Lepape A, et al. European surveillance of ICU-acquired infections (HELICS-ICU): methods and main results. J Hosp Infect. 2007; 65:171–3. https://doi.org/10.1016/S0195-6701(07)60038-3 PMID: 17540265
2. Davidoff F. Heterogeneity Is Not Always Noise. JAMA. 2009; 302(23):2580–6. https://doi.org/10.1001/jama.2009.1845 PMID: 20009058
3. Timsit JF, L’Hériteau F, Lepape A, Français A, Ruckly S, Venier AG, et al. A multicentre analysis of catheter-related infection based on a hierarchical model. Intensive Care Med. 2012; 38(10):1662–72. https://doi.org/10.1007/s00134-012-2645-6 PMID: 22797354
4. Pronovost PJ, Goeschel CA, Colantuoni E, Watson S, Lubomski LH, Berenholtz SM, et al. Sustaining reductions in catheter related bloodstream infections in Michigan intensive care units: observational study. BMJ. 2010; 340:c309. https://doi.org/10.1136/bmj.c309 PMID: 20133365
5. Mimoz O, Lucet JC, Kerforne T, Pascal J, Souweine B, Goudet V, et al. Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial. Lancet. 2015 Nov 21; 386(10008):2069–77. https://doi.org/10.1016/S0140-6736(15) 00244-5 PMID: 26388532
6. Soufir L, Timsit J, Mahe C, Carlet J, Regnier B, Chevret S. Attributable Morbidity and Mortality of Catheter-Related Septicemia in Critically Ill Patients: A Matched, Risk-Adjusted, Cohort Study. Infection Control and Hospital Epidemiology, vol. 20, no. 6, 1999, pp. 396–401. JSTOR, www.jstor.org/stable/10.1086/501639.
7. O’Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control. 2011; 39(4 Suppl 1):S1–34. https://doi.org/10.1016/j.ajic.2011.01.003 PMID: 21511081.
8. Timsit JF, Dubois Y, Minet C, Bonadona A, Lugosi M, Ara-Somohano C, et al. New materials and devices for preventing catheter-related infections. Annals of Intensive Care. 2011; 1:34. https://doi.org/10.1186/2110-5820-1-34 PMID: 21906266
9. French National Authority for Health. Choices in Methods for Economic Evaluation: a methodological guide. http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-10/choices_in_methods_for_economic_evaluation.pdf (2012). Accessed 15 Jul 2013. 2012.
10. Weinstein MC, Fineberg HV, Elstein AS, Frazier HS, Neuhauser D, Neutra RR. Clinical Decision Analysis. Philadelphia: WB Saunders Company; 1980.
11. Beck JR, Pauker SG. The Markov Process in Medical Prognosis. Med Decis Making. 1983; 3(4):419. https://doi.org/10.1177/0272989X8300300403 PMID: 6668990
12. Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making. 1993; 13(4):322–38. https://doi.org/10.1177/0272989X9301300409 PMID: 8246705
13. Janssen J, Limnios N. Semi-markov models and applications. Norwell: Kluwer Academic Publishers; 1999. 432 p.
14. Jackson C.H. (2011). Multi-State Models for Panel Data: The msm Package for R., Journal of Statistical Software, 38(8), 1–29. URL http://www.jstatsoft.org/v38/i08/.
15. Schwebel C, Lucet JC, Vesin A, Arrault X, Calvino-Gunther S, Bouadma L, et al. Economic evaluation of chlorhexidine-impregnated sponges for preventing catheter-related infections in critically ill adults in the Dressing Study. Crit Care Med. 2012; 40(1):11–7. https://doi.org/10.1097/CCM.0b013e31822f0604PMID: 21926570.
16. Garrigues B. Étude CRRéa: Évaluation médico-économique du Coût Réel d’une journée en RÉAnimation (Medico-economic evaluation of the Real Cost of a day in ICU). http://www.snmrhp.org/Data/ModuleGestionDeContenu/application/880.pdf 2010. Accessed 30 March 2015.
17. Crawford AG, Fuhr JP, Rao B. Cost-Benefit Analysis of Chlorhexidine Gluconate Dressing in the Prevention of Catheter-Related Bloodstream Infections. Infect Control Hosp Epidemiol. 2004; 25(8):668–74. https://doi.org/10.1086/502459 PMID: 15357159
18. Ye X, Rupnow M, Bastide P, Lafuma A, Ovington L, Jarvis WR. Economic impact of use of chlorhexidine-impregnated sponge dressing for prevention of central line-associated infections in the United States. Am J Infect Control. 2011; 39(8):647–54. https://doi.org/10.1016/j.ajic.2010.11.008 PMID: 21641681.
19. Maunoury F, Motrunich A, Palka-Santini M, Bernatchez SF, Ruckly S, Timsit J-F (2015) Cost-Effectiveness Analysis of a Transparent Antimicrobial Dressing for Managing Central Venous and Arterial Catheters in Intensive Care Units. PLoS ONE 10(6): e0130439. https://doi.org/10.1371/journal.pone. 0130439 PMID: 26086783
20. Timsit JF, Mimoz O, Mourvillier B, Souweine B, Garrouste-Orgeas M, Alfandari S, et al. Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults. Am J Respir Crit Care Med. 2012; 186(12):1272–8. https://doi.org/10.1164/rccm.201206-1038OC PMID: 23043083.
21. Timsit JF, Schwebel C, Bouadma L, Geffroy A, Garrouste-Orgeas M, Pease S, et al. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults. J Am Med Assoc. 2009; 301(12):1231–41.
22. Timsit JF, Bouadma L, Mimoz O, Parienti JJ, Garrouste-Orgeas M, Alfandari S, et al. Jugular versus femoral short-term catheterization and risk of infection in intensive care unit patients. Causal analysis of two randomized trials. Am J Resp Crit Care Med. 2013; 188(10), 1232–9. https://doi.org/10.1164/rccm. 201303-0460OC PMID: 24127770